News from the FDA/CDC

FDA approves starting dose of roflumilast

Taking a smaller dose of a drug currently used to treat COPD may prevent patients from discontinuing their use of the larger therapeutic dose.

News from the FDA/CDC

Nebulized LAMA for COPD approved

A long-acting muscarinic antagonist for COPD is now available in a nebulizer form in the United States.

Conference Coverage

Omalizumab helps asthma COPD overlap patients

Researchers presented the findings of a study of one of the largest observational cohorts to date of patients with asthma COPD overlap (ACO) at...